Login / Signup

The Cost-Effectiveness of a COVID-19 Vaccine in a Danish Context.

Kristian DebrabantLone GrønbækChristian Kronborg
Published in: Clinical drug investigation (2021)
The cost effectiveness of a COVID-19 vaccine is sensitive to whether or not productivity losses are included in the analyses. Without productivity losses, the elderly population should always be part of the target group for a COVID-19 vaccination programme. Taking productivity losses into account, at least in the case of low vaccine prices, vaccinating the younger population first can actually be cost effective.
Keyphrases
  • coronavirus disease
  • sars cov
  • climate change
  • clinical trial
  • study protocol
  • randomized controlled trial